Barclays Lifts Evonik to Overweight as Methionine Shortages Bolster Prices
Barclays upgraded Evonik to Overweight from Equal Weight and raised its price target to €17 after supply disruptions in Asia tightened methionine availability and logistics. The bank sees higher spot prices and improved pricing power for non-Asian producers like Evonik, revising its 2026 EBITDA estimate upward and highlighting Evonik's energy hedgi…